SABBY MANAGEMENT, LLC - Q1 2019 holdings

$208 Million is the total value of SABBY MANAGEMENT, LLC's 80 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 90.9% .

 Value Shares↓ Weighting
BuyBIOGEN INCcall$54,438,000
+5928.6%
2,303
+7576.7%
26.15%
+13042.2%
SellSPDR S&P 500 ETFput$50,168,000
-53.6%
1,776
-59.0%
24.10%
+1.2%
NewISHARES TRput$33,925,0002,216
+100.0%
16.30%
NewCORMEDIX INCput$7,325,0007,751
+100.0%
3.52%
BuyFIBROGEN INCput$5,951,000
+40.5%
1,095
+19.7%
2.86%
+206.8%
NewISHARES TRcall$5,511,000360
+100.0%
2.65%
ODT SellODONATE THERAPEUTICS INC$5,168,000
-64.0%
233,727
-54.9%
2.48%
-21.4%
SellSPDR S&P BIOTECHput$4,527,000
-80.4%
500
-84.5%
2.18%
-57.2%
SellBIOGEN INCput$3,498,000
-90.8%
148
-88.3%
1.68%
-79.9%
BCLI SellBRAINSTORM CELL THERAPEUTICS INC$3,234,000
-9.9%
745,205
-26.3%
1.55%
+97.0%
SellAMARIN CORPORATION PLCcall$3,072,000
-49.4%
1,480
-66.8%
1.48%
+10.5%
ORMP SellORAMED PHARMACEUTICALS INC$2,481,000
-11.4%
681,500
-27.0%
1.19%
+93.5%
NewWAVE LIFE SCIENCES LTDcall$2,370,000610
+100.0%
1.14%
LOOP NewLOOP INDUSTRIES INC$1,968,000248,436
+100.0%
0.94%
SOLO BuyELECTRAMECCANICA VEHS CORP$1,877,000
+781.2%
527,200
+163.6%
0.90%
+1819.1%
NewFIBROGEN INCcall$1,826,000336
+100.0%
0.88%
BIIB SellBIOGEN INC$1,655,000
-95.6%
7,000
-94.4%
0.80%
-90.5%
PAVMZ SellPAVMED INC*w$1,426,000
+13.6%
3,667,799
-6.5%
0.68%
+148.2%
NewIONIS PHARMACEUTICALS INCcall$1,229,0001,848
+100.0%
0.59%
GNPX SellGENPREX INC$911,000
-0.4%
585,573
-29.6%
0.44%
+117.9%
UMRX SellUNUM THERAPEUTICS INC$906,000
-53.9%
206,358
-53.8%
0.44%
+0.5%
CODX NewCO-DIAGNOSTICS INC$820,000773,330
+100.0%
0.39%
FGEN SellFIBROGEN INC$717,000
-65.9%
13,195
-70.9%
0.34%
-25.5%
ABILF BuyABILITY INC$676,000
-0.6%
393,972
+10.1%
0.32%
+116.7%
SellMICROBOT MED INC$646,000
+330.7%
83,333
-4.5%
0.31%
+839.4%
CYTR SellCYTRX CORP$629,000
-24.5%
974,945
-47.5%
0.30%
+65.0%
NewINPIXON COM$564,000691,828
+100.0%
0.27%
OPGN BuyOPGEN INC$562,000
+72.4%
929,831
+270.3%
0.27%
+275.0%
AQB SellAQUABOUNTY TECHNOLOGIES INC$561,000
-13.6%
256,030
-19.1%
0.27%
+88.8%
VBLT SellVASCULAR BIOGENICS LTD$498,000
-78.4%
327,504
-86.2%
0.24%
-52.8%
NVAX NewNOVAVAX INC$474,000860,000
+100.0%
0.23%
NewNOVAVAX INCput$474,0008,600
+100.0%
0.23%
ISR SellISORAY INC$467,000
-30.9%
1,279,684
-43.2%
0.22%
+50.3%
SYN SellSYNTHETIC BIOLOGICS INC$465,000
-25.7%
684,926
-38.7%
0.22%
+61.6%
TRNX NewTARONIS TECHNOLOGIES INC$459,000721,600
+100.0%
0.22%
MDGSW SellMEDIGUS LTD*w$457,000
-12.5%
1,014,587
-2.8%
0.22%
+91.3%
SellMANNKIND CORPput$398,000
+57.3%
2,018
-15.5%
0.19%
+241.1%
EYEN SellEYENOVIA INC$392,000
-22.4%
65,500
-63.0%
0.19%
+69.4%
SCON SellSUPERCONDUCTOR TECHNOLOGIES INC$392,000
-6.9%
261,470
-19.9%
0.19%
+102.2%
VXRT NewVAXART INC$382,000197,001
+100.0%
0.18%
VTVT NewVTV THERAPEUTICS INCcl a$382,000223,172
+100.0%
0.18%
BuyALTIMMUNE INCput$368,000
+164.7%
1,269
+88.6%
0.18%
+471.0%
NURO SellNEUROMETRIX INC$338,000
-33.1%
307,509
-53.7%
0.16%
+45.9%
OGEN NewORAGENICS INC$299,000510,679
+100.0%
0.14%
DMPI SellDELMAR PHARMACEUTICALS INC$243,000
-50.2%
496,502
-64.8%
0.12%
+9.3%
BuyVIKING THERAPEUTICS INCcall$244,000
+216.9%
245
+145.0%
0.12%
+588.2%
HSGX NewHISTOGENICS CORP$220,0001,900,100
+100.0%
0.11%
APOP BuyCELLECT BIOTECHNOLOGY LTDads$214,000
+154.8%
211,854
+429.2%
0.10%
+472.2%
NewKARYOPHARM THERAPEUTICS INCcall$210,000359
+100.0%
0.10%
BLPH NewBELLEROPHON THERAPEUTICS INC$202,000308,912
+100.0%
0.10%
SellREWALK ROBOTICS LTD$198,000
-65.2%
914,857
-72.0%
0.10%
-24.0%
PYDS NewPAYMENT DATA SYS INC$193,00073,773
+100.0%
0.09%
NewTITAN PHARMACEUTICALS INCput$184,0001,031
+100.0%
0.09%
CRMD NewCORMEDIX INC$171,00018,118
+100.0%
0.08%
AKAOQ NewACHAOGEN INC$159,000348,400
+100.0%
0.08%
KPTI NewKARYOPHARM THERAPEUTICS INC$146,00025,000
+100.0%
0.07%
HMTV NewHEMISPHERX BIOPHARMA INC$113,000708,417
+100.0%
0.05%
BuyCEL-SCI CORPput$110,000
+243.8%
312
+183.6%
0.05%
+657.1%
CUR SellNEURALSTEM INC$106,000
-78.4%
238,813
-84.7%
0.05%
-52.8%
NewNOVAN INC$82,00086,225
+100.0%
0.04%
MKGI SellMONAKER GROUP INC$73,000
-88.1%
35,970
-93.0%
0.04%
-74.1%
FCEL BuyFUELCELL ENERGY INC$59,000
+195.0%
241,523
+550.8%
0.03%
+600.0%
SGLBW SellSIGMA LABS INC*w$57,000
-23.0%
88,467
-53.1%
0.03%
+68.8%
PTI NewPROTEOSTASIS THERAPEUTICS INC$39,00030,900
+100.0%
0.02%
ONTXW SellONCONOVA THERAPEUTICS INC*w$35,000
+34.6%
641,362
-3.0%
0.02%
+183.3%
SPHS BuySOPHIRIS BIO INC$33,000
+230.0%
33,643
+179.3%
0.02%
+700.0%
NewAPPLIED DNA SCIENCES INCput$32,000288
+100.0%
0.02%
NewPROTEOSTASIS THERAPEUTICS INCcall$28,000220
+100.0%
0.01%
SellPLURISTEM THERAPEUTICS INCput$23,000
-4.2%
239
-22.7%
0.01%
+120.0%
NewCELSION CORPcall$20,000100
+100.0%
0.01%
BLIN SellBRIDGELINE DIGITAL INC$16,000
-91.1%
100,000
-87.2%
0.01%
-80.0%
BLRX NewBIOLINE RX LTDads$16,00036,999
+100.0%
0.01%
SellFUELCELL ENERGY INCput$11,000
-64.5%
456
-19.3%
0.01%
-28.6%
NewNOVAVAX INCcall$8,000153
+100.0%
0.00%
NewACHAOGEN INCput$6,000136
+100.0%
0.00%
BNTCW SellBENITEC BIOPHARMA LTD*w$6,000
-14.3%
57,949
-0.2%
0.00%
+50.0%
PHIOW  PHIO PHARMACEUTICALS CORP*w$5,0000.0%194,9590.0%0.00%
+100.0%
APDNW SellAPPLIED DNA SCIENCES INC*w$4,000
+100.0%
192,302
-68.1%
0.00%
ExitDBV TECHNOLOGIES SAcall$0-116
-100.0%
0.00%
SRNE ExitSORRENTO TECH INC$0-84,536
-100.0%
0.00%
NewAETERNA ZENTARIS INCput$1,00012
+100.0%
0.00%
ExitCONATUS PHARMACEUTICALS INCcall$0-187
-100.0%
0.00%
NSPRZ SellINSPIREMD INC*w$1,000
-50.0%
1,067,324
-25.5%
0.00%
SCYX ExitSCYNEXIS INC$0-15,764
-100.0%
-0.00%
MNKD ExitMANNKIND CORP$0-12,797
-100.0%
-0.00%
SOLOW ExitELECTRAMECCANICA VEHICLES CORP*w$0-30,905
-100.0%
-0.00%
KTOV ExitKITOV PHARMA LTD.$0-19,980
-100.0%
-0.00%
CLSN ExitCELSION CORPORATION$0-10,843
-100.0%
-0.00%
ExitOPHTHOTECH CORPput$0-133
-100.0%
-0.00%
APDN ExitAPPLIED DNA SCIENCES INC$0-60,835
-100.0%
-0.01%
OTLKW ExitOUTLOOK THERAPEUTICS INC*w$0-177,439
-100.0%
-0.01%
ExitDURECT CORPcall$0-549
-100.0%
-0.01%
CTXR ExitCITIUS PHARMACEUTICALS INC$0-28,045
-100.0%
-0.01%
AVGR ExitAVINGER INC$0-112,270
-100.0%
-0.01%
CHEK ExitCHECK CAP LTD$0-16,979
-100.0%
-0.01%
CRMD ExitCORMEDIX INC$0-30,661
-100.0%
-0.01%
ExitCORMEDIX INCput$0-305
-100.0%
-0.01%
ExitSUNESIS PHARMACEUTICALS INCcall$0-1,141
-100.0%
-0.01%
ExitMANNKIND CORPcall$0-449
-100.0%
-0.01%
BIOC ExitBIOCEPT INC$0-57,505
-100.0%
-0.01%
ExitSYNERGY PHARMACEUTICALS INCcall$0-5,382
-100.0%
-0.01%
FCSC ExitFIBROCELL SCIENCE INC$0-42,400
-100.0%
-0.01%
DRRX ExitDURECT CORP$0-131,900
-100.0%
-0.01%
MOSY ExitMOSYS INC$0-398,408
-100.0%
-0.02%
ExitMARINUS PHARMACEUTICALS INCcall$0-287
-100.0%
-0.02%
SNES ExitSENESTECH INC$0-146,530
-100.0%
-0.02%
CVM ExitCEL-SCI CORP$0-32,256
-100.0%
-0.02%
NSPR ExitINSPIREMD INC$0-560,562
-100.0%
-0.02%
CHEKZ ExitCHECK CAP LTD*w$0-252,155
-100.0%
-0.02%
ONTX ExitONCONOVA THERAPEUTICS INC$0-47,794
-100.0%
-0.02%
CHFS ExitCHF SOLUTIONS INC$0-221,033
-100.0%
-0.02%
ExitLM FDG AMER INC$0-98,927
-100.0%
-0.03%
ExitTENAX THERAPEUTICS INC$0-108,427
-100.0%
-0.03%
SNSS ExitSUNESIS PHARMACEUTICALS INC$0-400,140
-100.0%
-0.04%
APHB ExitAMPLIPHI BIOSCIENCES CORP$0-816,095
-100.0%
-0.04%
ExitOPHTHOTECH CORPcall$0-1,438
-100.0%
-0.04%
NOVN ExitNOVAN INC$0-213,064
-100.0%
-0.04%
RSLS ExitRESHAPE LIFESCIENCES INC$0-732,648
-100.0%
-0.04%
RTTR ExitRITTER PHARMACEUTICALS INC$0-343,642
-100.0%
-0.04%
ACST ExitACASTI PHARMA INCcl a$0-275,000
-100.0%
-0.05%
ExitSESEN BIO INCput$0-1,830
-100.0%
-0.06%
JAGX ExitJAGUAR HEALTH INC$0-1,311,580
-100.0%
-0.07%
RKDA ExitARCADIA BIOSCIENCES INC$0-95,682
-100.0%
-0.07%
SNOA ExitSONOMA PHARMACEUTICALS INC$0-465,000
-100.0%
-0.07%
ZSAN ExitZOSANO PHARMA CORP$0-167,403
-100.0%
-0.08%
HTBX ExitHEAT BIOLOGICS INC$0-391,985
-100.0%
-0.08%
AYTU ExitAYTU BIOSCIENCE INC$0-515,002
-100.0%
-0.09%
IPCIF ExitINTELLIPHARMACEUTICS INTL INC$0-1,944,978
-100.0%
-0.10%
ALT ExitALTIMMUNE INC$0-237,921
-100.0%
-0.11%
ATOS ExitATOSSA GENETICS INC$0-502,448
-100.0%
-0.11%
PHIO ExitPHIO PHARMACEUTICALS$0-1,575,157
-100.0%
-0.11%
ExitVIKING THERAPEUTICS INC$0-72,500
-100.0%
-0.12%
MGTA ExitMAGENTA THERAPEUTICS INC$0-107,156
-100.0%
-0.13%
TNXP ExitTONIX PHARMACEUTICALS HLDG$0-296,727
-100.0%
-0.14%
SLNO ExitSOLENO THERAPEUTICS INC$0-529,921
-100.0%
-0.20%
ExitSANGAMO THERAPEUTICS INC$0-81,161
-100.0%
-0.20%
SGMO ExitSANGAMO THERAPEUTICS INCput$0-824
-100.0%
-0.21%
AMRN ExitAMARIN CORPORATION PLCadr$0-85,038
-100.0%
-0.26%
OTLK ExitOUTLOOK THERAPEUTICS INC$0-2,786,448
-100.0%
-0.31%
ExitAVEO PHARMACEUTICALS INCcall$0-10,731
-100.0%
-0.38%
ExitMADRIGAL PHARMACEUTICALS INCcall$0-154
-100.0%
-0.38%
ExitNEKTAR THERAPEUTICScall$0-650
-100.0%
-0.47%
OPHT ExitOPHTHOTECH CORP$0-2,037,460
-100.0%
-0.54%
NKTR ExitNEKTAR THERAPEUTICS$0-78,915
-100.0%
-0.57%
ExitNEKTAR THERAPEUTICSput$0-817
-100.0%
-0.59%
XERS ExitXERIS PHARMACEUTICALS INC$0-202,916
-100.0%
-0.76%
ExitZOGENIX INCcall$0-991
-100.0%
-0.80%
ExitAMARIN CORPORATION PLCput$0-2,745
-100.0%
-0.82%
XBI ExitSPDR S&P BIOTECHetf$0-62,266
-100.0%
-0.98%
ExitSPDR S&P BIOTECHcall$0-694
-100.0%
-1.10%
ExitASTRAZENECA PLCcall$0-1,485
-100.0%
-1.24%
ESPR ExitESPERION THERAPEUTICS INC$0-138,958
-100.0%
-1.41%
ExitSAREPTA THERAPEUTICS INCput$0-864
-100.0%
-2.07%
ExitASTRAZENECA PLCput$0-3,312
-100.0%
-2.77%
ExitSAREPTA THERAPEUTICS INCcall$0-1,746
-100.0%
-4.19%
ExitESPERION THERAPEUTICS INCput$0-8,467
-100.0%
-8.57%
ExitISHARES RUSSELL 2000put$0-4,300
-100.0%
-12.67%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPDR S&P 500 ETF TRUST UNIT37Q3 202349.1%
ISHARES TR35Q3 202352.2%
SPDR S&P BIOTECHNOLOGY32Q3 202212.8%
AMARIN CORP PLC30Q4 20212.0%
BIOGEN INC24Q1 202126.2%
SAREPTA THERAPEUTICS INC24Q3 20204.6%
BIOGEN INC23Q1 202113.7%
SAREPTA THERAPEUTICS INC22Q3 20206.2%
BRAINSTORM CELL THERAPEUTICS INC21Q3 20231.6%
VERTEX PHARMACEUTICALS INC20Q1 201812.6%

View SABBY MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
SABBY MANAGEMENT, LLC Q1 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AGM GROUP HOLDINGS, INC.January 10, 2023627,9362.6%
Bit Digital, IncJanuary 10, 20233,166,9173.8%
Cingulate Inc.January 10, 2023105.0%
Context Therapeutics Inc.January 10, 2023796,7065.0%
HeartBeam, Inc.January 10, 2023271,7883.4%
PharmaCyte Biotech, Inc.January 10, 2023934,4565.0%
Rebus Holdings, Inc.Sold outJanuary 10, 202300.0%
TANTECH HOLDINGS LTDJanuary 10, 202341,5000.6%
Quanergy Systems, Inc.January 04, 2023936,9055.8%
TuanChe LtdJanuary 04, 20232,384,71310.0%

View SABBY MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-03
SC 13G2024-01-03
SC 13G2024-01-03
SC 13G2024-01-03

View SABBY MANAGEMENT, LLC's complete filings history.

Compare quarters

Export SABBY MANAGEMENT, LLC's holdings